Sirolimus-induced secondary pulmonary alveolar proteinosis
Pulmonary alveolar proteinosis (PAP) is a rare pulmonary syndrome that is characterized by the accumulation of excess surfactant in the alveolar space, leading to impaired gas exchange. Sirolimus-induced PAP is an extremely rare entity that has only been described in the literature in a small number...
Main Authors: | Stephanie Wang, MD, Elinor Lee, MD, PhD, Ryan Lau, MD, Tisha Wang, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Respiratory Medicine Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007121002288 |
Similar Items
-
Reversible sirolimus-induced pulmonary alveolar proteinosis in a renal transplant patient
by: David Eugenio Hinojosa-González, et al.
Published: (2020-01-01) -
Interstitial lung disease as a late complication of pulmonary alveolar proteinosis
by: Alexandre Semionov, MD, PhD, et al.
Published: (2019-05-01) -
Alveolar macrophage lipid burden correlates with clinical improvement in patients with pulmonary alveolar proteinosis
by: Elinor Lee, et al.
Published: (2024-02-01) -
The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review
by: Ali Ataya, et al.
Published: (2021-11-01) -
Pulmonary alveolar proteinosis
by: B. Crestani, et al.
Published: (2011-06-01)